Quintara Biosciences Launches Nanopore Genotyping Validation Service

BOSTON, Nov. 9, 2026 /CourierPR/ -- Quintara Biosciences, a nationwide provider of genomics and molecular biology services, has introduced a new Nanopore-based Genotyping Validation service aimed at rapidly confirming isolated single clones. This innovative service leverages full-length amplicon sequencing, capable of handling amplicons from 100 base pairs (bp) to 25 kilobases (kb), to resolve complex CRISPR edits and phase variants end-to-end. The service reconstructs distinct allele sequences, providing researchers with comprehensive insights into the genetic makeup of their samples.

The new service is designed to be accessible and flexible, with four different tiers to accommodate various research needs. The Basic tier, starting at $10, supports up to 1,000 reads and can identify up to three alleles. The Standard tier, priced at $30, offers a higher read depth of up to 5,000 reads and can identify six alleles. For more complex genotyping projects, the Plus tier, priced at $60, provides up to 10,000 reads and can identify 12 alleles. The top tier, the Huge tier, priced at $120, supports up to 20,000 reads and can identify 24 alleles, making it suitable for the most demanding research scenarios.

Quintara Biosciences has established a nationwide drop box network to ensure that samples can be quickly delivered to the lab. Once received, the samples undergo established Nanopore sequencing and bioinformatics workflows, with results delivered within one business day across all four service levels. The interactive HTML report provides researchers with a comprehensive view of their samples, including full-length allele sequences, estimated allele frequencies, and supporting read counts. Additionally, researchers receive FASTA, FASTQ, allele-frequency, alignment, and per-base data files for further analysis.

The service is particularly useful for a wide range of applications, including confirming wild-type, heterozygous, and homozygous clones, validating CRISPR knockout, HDR/knock-in, and base-editing, and detecting and phasing single nucleotide polymorphisms (SNPs), insertions, deletions, and multiple edits. It is also well-suited for reconstructing complex alleles in cancer cell lines, polyploid or aneuploid genomes, and amplified loci. Furthermore, the service enables genotype-based sample stratification for downstream analysis, making it a valuable tool for researchers in various fields.

Quintara Biosciences operates labs in Boston, San Francisco, Los Angeles, San Diego, and Houston, with an additional site in Kentucky currently under development. The company offers sequencing, cloning, and gene synthesis solutions for academic, biotech, and pharmaceutical clients, delivering fast, reliable, and cost-effective services designed around customer needs.